These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 19570000)
1. Subcutaneous bioavailability of a PRIMATIZED IgG1 anti-human CD4 monoclonal antibody is dose dependent in transgenic mice bearing human CD4. Davis CB; Bugelski PJ Drug Deliv; 1998; 5(2):95-100. PubMed ID: 19570000 [TBL] [Abstract][Full Text] [Related]
2. Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4. Davis CB; Garver EM; Kwok DC; Urbanski JJ Drug Metab Dispos; 1996 Sep; 24(9):1032-7. PubMed ID: 8886616 [TBL] [Abstract][Full Text] [Related]
3. A primatized MAb to human CD4 causes receptor modulation, without marked reduction in CD4+ T cells in chimpanzees: in vitro and in vivo characterization of a MAb (IDEC-CE9.1) to human CD4. Anderson D; Chambers K; Hanna N; Leonard J; Reff M; Newman R; Baldoni J; Dunleavy D; Reddy M; Sweet R; Truneh A Clin Immunol Immunopathol; 1997 Jul; 84(1):73-84. PubMed ID: 9191886 [TBL] [Abstract][Full Text] [Related]
4. Clinical and immunologic effects of a PRIMATIZED anti-CD4 monoclonal antibody in active rheumatoid arthritis: results of a phase I, single dose, dose escalating trial. Yocum DE; Solinger AM; Tesser J; Gluck O; Cornett M; O'Sullivan F; Nordensson K; Dallaire B; Shen CD; Lipani J J Rheumatol; 1998 Jul; 25(7):1257-62. PubMed ID: 9676753 [TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacodynamics of keliximab and clenoliximab in transgenic mice bearing human CD4. Sharma A; Davis CB; Tobia LA; Kwok DC; Tucci MG; Gore ER; Herzyk DJ; Hart TK J Pharmacol Exp Ther; 2000 Apr; 293(1):33-41. PubMed ID: 10734150 [TBL] [Abstract][Full Text] [Related]
6. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule. Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893 [TBL] [Abstract][Full Text] [Related]
7. Optimization of monoclonal antibody delivery via the lymphatics: the dose dependence. Steller MA; Parker RJ; Covell DG; Holton OD; Keenan AM; Sieber SM; Weinstein JN Cancer Res; 1986 Apr; 46(4 Pt 1):1830-4. PubMed ID: 3948166 [TBL] [Abstract][Full Text] [Related]
8. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage. Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of administration of a human anti-CD4 monoclonal antibody, HM6G, in nonhuman primates. Fishwild DM; Hudson DV; Deshpande U; Kung AH Clin Immunol; 1999 Aug; 92(2):138-52. PubMed ID: 10444358 [TBL] [Abstract][Full Text] [Related]
10. Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody. Chirmule N; Truneh A; Haecker SE; Tazelaar J; Gao Gp; Raper SE; Hughes JV; Wilson JM J Immunol; 1999 Jul; 163(1):448-55. PubMed ID: 10384148 [TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287 [TBL] [Abstract][Full Text] [Related]
12. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse. Margenthaler JA; Flye MW J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414 [TBL] [Abstract][Full Text] [Related]
13. A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis. Mould DR; Davis CB; Minthorn EA; Kwok DC; Elliott MJ; Luggen ME; Totoritis MC Clin Pharmacol Ther; 1999 Sep; 66(3):246-57. PubMed ID: 10511060 [TBL] [Abstract][Full Text] [Related]
14. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac. Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783 [TBL] [Abstract][Full Text] [Related]